Literature DB >> 28799781

MicroRNA-29c Prevents Pulmonary Fibrosis by Regulating Epithelial Cell Renewal and Apoptosis.

Ting Xie1, Jiurong Liang1, Yan Geng1, Ningshan Liu1, Adrianne Kurkciyan1, Vrishika Kulur1, Dong Leng2, Nan Deng3, Zhenqiu Liu3, Jianbo Song4, Peter Chen1, Paul W Noble1, Dianhua Jiang1.   

Abstract

Successful repair and renewal of alveolar epithelial cells (AECs) are critical in prohibiting the accumulation of myofibroblasts in pulmonary fibrogenesis. MicroRNAs (miRNAs) are multifocal regulators involved in lung injury and repair. However, the contribution of miRNAs to AEC2 renewal and apoptosis is incompletely understood. We report that miRNA-29c (miR-29c) expression is lower in AEC2s of individuals with idiopathic pulmonary fibrosis than in healthy lungs. Epithelial cells overexpressing miR-29c show higher proliferative rates and viability. miR-29c protects epithelial cells from apoptosis by targeting forkhead box O3a (Foxo3a). Both overexpression of miR-29c conventionally and AEC2s specifically lead to less fibrosis and better recovery in vivo. Furthermore, deficiency of miR-29c in AEC2s results in higher apoptosis and reduced epithelial renewal. Interestingly, a gene network including a subset of apoptotic genes was coregulated by both Toll-like receptor 4 and miR-29c. Taken together, miR-29c maintains epithelial integrity and promotes recovery from lung injury, thereby attenuating lung fibrosis in mice.

Entities:  

Keywords:  alveolar epithelial type II cell apoptosis; alveolar epithelial type II cell renewal; microRNA-29c; pulmonary fibrosis

Mesh:

Substances:

Year:  2017        PMID: 28799781      PMCID: PMC5765420          DOI: 10.1165/rcmb.2017-0133OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  50 in total

1.  MicroRNA-127 inhibits lung inflammation by targeting IgG Fcγ receptor I.

Authors:  Ting Xie; Jiurong Liang; Ningshan Liu; Qingguo Wang; Yuhang Li; Paul W Noble; Dianhua Jiang
Journal:  J Immunol       Date:  2012-01-27       Impact factor: 5.422

2.  miR-34a promotes fibrosis in aged lungs by inducing alveolarepithelial dysfunctions.

Authors:  Huachun Cui; Jing Ge; Na Xie; Sami Banerjee; Yong Zhou; Rui-Ming Liu; Victor J Thannickal; Gang Liu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-12-15       Impact factor: 5.464

3.  Expression analysis of serum microRNAs in idiopathic pulmonary fibrosis.

Authors:  Ping Li; Juan Li; Tengfei Chen; Huaqi Wang; Heying Chu; Jingxia Chang; Wenqiao Zang; Yuanyuan Wang; Yunyun Ma; Yuwen Du; Guoqiang Zhao; Guojun Zhang
Journal:  Int J Mol Med       Date:  2014-03-24       Impact factor: 4.101

4.  Measuring ER stress and the unfolded protein response using mammalian tissue culture system.

Authors:  Christine M Oslowski; Fumihiko Urano
Journal:  Methods Enzymol       Date:  2011       Impact factor: 1.600

5.  The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ.

Authors:  Feng Ma; Sheng Xu; Xingguang Liu; Qian Zhang; Xiongfei Xu; Mofang Liu; Minmin Hua; Nan Li; Hangping Yao; Xuetao Cao
Journal:  Nat Immunol       Date:  2011-07-24       Impact factor: 25.606

6.  Cre-lox-regulated conditional RNA interference from transgenes.

Authors:  Andrea Ventura; Alexander Meissner; Christopher P Dillon; Michael McManus; Phillip A Sharp; Luk Van Parijs; Rudolf Jaenisch; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-06       Impact factor: 11.205

7.  The nuclear RNase III Drosha initiates microRNA processing.

Authors:  Yoontae Lee; Chiyoung Ahn; Jinju Han; Hyounjeong Choi; Jaekwang Kim; Jeongbin Yim; Junho Lee; Patrick Provost; Olof Rådmark; Sunyoung Kim; V Narry Kim
Journal:  Nature       Date:  2003-09-25       Impact factor: 49.962

8.  The MicroRNA 29 Family Promotes Type II Cell Differentiation in Developing Lung.

Authors:  Wei Guo; Houda Benlhabib; Carole R Mendelson
Journal:  Mol Cell Biol       Date:  2016-07-29       Impact factor: 4.272

9.  Disruption of miR-29 Leads to Aberrant Differentiation of Smooth Muscle Cells Selectively Associated with Distal Lung Vasculature.

Authors:  Leah Cushing; Stefan Costinean; Wei Xu; Zhihua Jiang; Lindsey Madden; Pingping Kuang; Jingshu Huang; Alexandra Weisman; Akiko Hata; Carlo M Croce; Jining Lü
Journal:  PLoS Genet       Date:  2015-05-28       Impact factor: 5.917

10.  miR-34 miRNAs Regulate Cellular Senescence in Type II Alveolar Epithelial Cells of Patients with Idiopathic Pulmonary Fibrosis.

Authors:  Supparerk Disayabutr; Eun Kyung Kim; Seung-Ick Cha; Gary Green; Ram P Naikawadi; Kirk D Jones; Jeffrey A Golden; Aaron Schroeder; Michael A Matthay; Jasleen Kukreja; David J Erle; Harold R Collard; Paul J Wolters
Journal:  PLoS One       Date:  2016-06-30       Impact factor: 3.240

View more
  20 in total

1.  Genome-wide integration of microRNA and transcriptomic profiles of differentiating human alveolar epithelial cells.

Authors:  Alessandra Castaldi; Masafumi Horie; Megan E Rieger; Mickael Dubourd; Mitsuhiro Sunohara; Kusum Pandit; Beiyun Zhou; Ite A Offringa; Crystal N Marconett; Zea Borok
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-05-20       Impact factor: 5.464

Review 2.  The roles of microRNAs played in lung diseases via regulating cell apoptosis.

Authors:  Qiaoling Huang; Li Chen; Qinqin Bai; Ting Tong; You Zhou; Zhongyu Li; Chunxue Lu; Shenghua Chen; Lili Chen
Journal:  Mol Cell Biochem       Date:  2021-08-16       Impact factor: 3.396

Review 3.  Role of MicroRNAs in Signaling Pathways Associated with the Pathogenesis of Idiopathic Pulmonary Fibrosis: A Focus on Epithelial-Mesenchymal Transition.

Authors:  Ana Ruth Cadena-Suárez; Hilda Arely Hernández-Hernández; Noé Alvarado-Vásquez; Claudia Rangel-Escareño; Bettina Sommer; María Cristina Negrete-García
Journal:  Int J Mol Sci       Date:  2022-06-14       Impact factor: 6.208

Review 4.  Decrypting the crosstalk of noncoding RNAs in the progression of IPF.

Authors:  Yujuan Wang; Han Xiao; Fenglian Zhao; Han Li; Rong Gao; Bingdi Yan; Jin Ren; Junling Yang
Journal:  Mol Biol Rep       Date:  2020-03-16       Impact factor: 2.316

Review 5.  Impact of Transcriptomics on Our Understanding of Pulmonary Fibrosis.

Authors:  Milica Vukmirovic; Naftali Kaminski
Journal:  Front Med (Lausanne)       Date:  2018-04-04

6.  MicroRNA29a Reverts the Activated Hepatic Stellate Cells in the Regression of Hepatic Fibrosis through Regulation of ATPase H⁺ Transporting V1 Subunit C1.

Authors:  Fei Jing; Yan Geng; Xin-Yi Xu; Hong-Yu Xu; Jin-Song Shi; Zheng-Hong Xu
Journal:  Int J Mol Sci       Date:  2019-02-13       Impact factor: 5.923

7.  Next-Generation Sequencing Profiles of the Methylome and Transcriptome in Peripheral Blood Mononuclear Cells of Rheumatoid Arthritis.

Authors:  Chia-Chun Tseng; Yuan-Zhao Lin; Chia-Hui Lin; Ruei-Nian Li; Chang-Yi Yen; Hua-Chen Chan; Wen-Chan Tsai; Tsan-Teng Ou; Cheng-Chin Wu; Wan-Yu Sung; Jeng-Hsien Yen
Journal:  J Clin Med       Date:  2019-08-22       Impact factor: 4.241

8.  Mesenchymal growth hormone receptor deficiency leads to failure of alveolar progenitor cell function and severe pulmonary fibrosis.

Authors:  Ting Xie; Vrishika Kulur; Ningshan Liu; Nan Deng; Yizhou Wang; Simon Coyle Rowan; Changfu Yao; Guanling Huang; Xue Liu; Forough Taghavifar; Jiurong Liang; Cory Hogaboam; Barry Stripp; Peter Chen; Dianhua Jiang; Paul W Noble
Journal:  Sci Adv       Date:  2021-06-09       Impact factor: 14.136

9.  Exploring the Mechanism Whereby Sinensetin Delays the Progression of Pulmonary Fibrosis Based on Network Pharmacology and Pulmonary Fibrosis Models.

Authors:  Yong Xu; Wen-Lu Hang; Xian-Mei Zhou; Qi Wu
Journal:  Front Pharmacol       Date:  2021-06-18       Impact factor: 5.810

10.  Targeting Follistatin like 1 ameliorates liver fibrosis induced by carbon tetrachloride through TGF-β1-miR29a in mice.

Authors:  Xin-Yi Xu; Yan Du; Xue Liu; Yilin Ren; Yingying Dong; Hong-Yu Xu; Jin-Song Shi; Dianhua Jiang; Xin Xu; Lian Li; Zheng-Hong Xu; Yan Geng
Journal:  Cell Commun Signal       Date:  2020-09-15       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.